3 news items
A Closer Look at 11 Analyst Recommendations For Intra-Cellular Therapies
ITCI
22 Jul 24
:
Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
ITCI
18 Jun 24
lumateperone a drug of choice for patients suffering with MDD who are having an inadequate response to antidepressant therapy," said Dr. Sharon Mates, Chairman
Where Intra-Cellular Therapies Stands With Analysts
ITCI
12 Jun 24
', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Intra-Cellular Therapies. This offers insight
- Prev
- 1
- Next